Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21625
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLi, Jia-
dc.contributor.authorZhang, Jin-
dc.contributor.authorTang, Weiting-
dc.contributor.authorMizu, Ruth K-
dc.contributor.authorKusumoto, Hirofumi-
dc.contributor.authorXiangWei, Wenshu-
dc.contributor.authorXu, Yuchen-
dc.contributor.authorChen, Wenjuan-
dc.contributor.authorAmin, Johansen B-
dc.contributor.authorPerozo, Eduardo-
dc.contributor.authorHu, Chun-
dc.contributor.authorKannan, Varun-
dc.contributor.authorKeller, Stephanie R-
dc.contributor.authorWilcox, William R-
dc.contributor.authorLemke, Johannes R-
dc.contributor.authorMyers, Scott J-
dc.contributor.authorSwanger, Sharon A-
dc.contributor.authorWollmuth, Lonnie P-
dc.contributor.authorPetrovski, Slavé-
dc.contributor.authorTraynelis, Stephen F-
dc.contributor.authorYuan, Hongjie-
dc.date2019-08-20-
dc.date.accessioned2019-08-26T06:32:28Z-
dc.date.available2019-08-26T06:32:28Z-
dc.date.issued2019-
dc.identifier.citationHuman mutation 2019; 40(12): 2393-2413-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/21625-
dc.description.abstractN-methyl-D-aspartate receptors (NMDARs) mediate slow excitatory postsynaptic transmission in central nervous system, thereby exerting a critical role in neuronal development and brain function. Rare genetic variants in the GRIN genes encoding NMDAR subunits segregated with neurological disorders. Here we summarize the clinical presentations for 18 patients harboring 12 de novo missense variants in GRIN1, GRIN2A, GRIN2B that alter residues in the M2 reentrant loop, a region that lines the pore and is intolerant to missense variation. These de novo variants were identified in children with a set of neurological and neuropsychiatric conditions. Evaluation of the receptor cell surface expression, pharmacological properties, and biophysical characteristics show that these variants can have modest changes in agonist potency, proton inhibition, and surface expression. However, voltage-dependent magnesium inhibition is significantly reduced in all variants. The NMDARs hosting a single copy of a mutant subunit showed a dominant reduction in magnesium inhibition for some variants. These variant NMDARs also show reduced calcium permeability and single channel conductance, as well as altered open probability. The data suggest that M2 missense variants increase NMDAR charge transfer in addition to varied and complex influences on NMDAR functional properties, which may underlie the patients' phenotypes. This article is protected by copyright. All rights reserved.-
dc.language.isoeng-
dc.subjectGluN-
dc.subjectautism-
dc.subjectchannelopathy-
dc.subjectepilepsy-
dc.subjectglutamate receptor-
dc.subjectintellectual disability-
dc.subjectmissense variants-
dc.subjectmovement disorder-
dc.subjectneurological diseases-
dc.subjecttranslation study-
dc.subjecttransmembrane domain-
dc.titleDe Novo GRIN Variants in NMDA Receptor M2 Channel Pore-Forming Loop Are Associated with Neurological Diseases.-
dc.typeJournal Article-
dc.identifier.journaltitleHuman mutation-
dc.identifier.affiliationDivision of Pediatric Neurology, Emory University School of Medicine, Atlanta, GA, 30322, USAen
dc.identifier.affiliationDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, 30322, USAen
dc.identifier.affiliationDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, Chinaen
dc.identifier.affiliationCenter for Functional Evaluation of Rare Variants (CFERV), Emory University School of Medicine, Atlanta, GA, 30322, USAen
dc.identifier.affiliationDivision of Medical Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USAen
dc.identifier.affiliationCentre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D,, AstraZeneca, Cambridge, CB4 0WG, UKen
dc.identifier.affiliationDepartment of Medicine, the University of Melbourne, Royal Melbourne Hospital, Melbourne, Victoria, 3050, Australiaen
dc.identifier.affiliationDepartment of Neurobiology & Behavior, Stony Brook University School of Medicine, Stony Brook, NY, 11794, USAen
dc.identifier.affiliationInstitute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig, Germany-
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.doi10.1002/humu.23895-
dc.identifier.orcid0000-0002-8127-7145-
dc.identifier.orcid0000-0002-1527-961X-
dc.identifier.pubmedid31429998-
dc.type.austinJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

12
checked on Mar 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.